Osteoarthritis · PDA-100
Ceres™ for the osteoarthritic joint
A single intra-articular application, studied against saline control across pain, function, and synovial inflammation.
Study summary
In an in vivo study, a single intra-articular application reduced patient-reported pain (VAS) and functional deficit (JFLS) at 30 and 60 days versus saline, alongside lower inflammatory cytokine levels in synovial fluid.
Pain (VAS)
Reduced
at 30 and 60 days vs saline
Function (JFLS)
Improved
functional deficit reduced
Synovial cytokines
Lower
inflammatory markers in synovial fluid
Full clinical dossier
Complete study design, endpoints, and data tables are available to qualified practices on request.